Pricing Log in Create free account

CytoMed Therapeutics Limited (GDTC) vs Kiora Pharmaceuticals, Inc. (KPRX)

CytoMed Therapeutics Limited and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. CytoMed Therapeutics Limited and Kiora Pharmaceuticals, Inc. are of similar size ($10.7M and $10.3M). Across the 11 metrics below, CytoMed Therapeutics Limited leads on 8 and Kiora Pharmaceuticals, Inc. on 3.

Valuation

Metric GDTC KPRX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.79 9.71
P/B 0.57 0.88 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.15 0.64
EV/Sales n/m (0.10) 9.21
Earnings yield (31.82%) (103.07%) (33.15%)
Free cash flow yield (0.38%) (58.10%) (25.50%)

Profitability

Metric GDTC KPRX Biotechnology median
Gross margin 0.00% 85.06% 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (56.36%) (56.36%)
Return on assets 0.00% (39.43%) (48.04%)
Return on invested capital 0.00% (44,053.91%) 0.00%

Growth

Metric GDTC KPRX Biotechnology median
Revenue growth (TTM) — 983.73% 6.02%
EPS growth (last fiscal year) (68.75%) (403.45%) 30.26%
Revenue growth, 5-year CAGR — 88.72% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GDTC KPRX Biotechnology median
Debt to equity 0.08 0.00 0.00
Current ratio 2.64 8.97 4.72
Net debt to EBITDA 0.86 1.33 0.96

Dividend

Metric GDTC KPRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GDTC KPRX Biotechnology median
Market cap 10.30m 10.66m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack